Editorial: moving towards the appropriate use of proton pump inhibitors

Abstract

LINKED CONTENTThis article is linked to Ghosh et al and Schnoll‐Sussman and Katz papers. To view these articles, visit https://doi.org/10.1111/apt.15522 and https://doi.org/10.1111/apt.15591.

Editorial: moving towards appropriate use of proton pump inhibitors. Authors’ reply

“…We thank Drs Kurlander and Rubenstein for their thoughtful comments on our article, which augments and supports many of the findings in their recent publications . We agree wholeheartedly that, while there are many potential adverse events associated with proton pump inhibitors (PPIs) and the drugs are (in some cases) prescribed for less than clear indications, the lay press—and, subsequently, patients and providers–have perhaps over‐reacted.…”

“…We call on the lay press to move to responsible reporting, including follow‐up articles, especially when follow‐up data contradict an initial publication. Our article and this editorial highlight the need for clinicians to use data in the context of individual patients and, while being careful to use PPIs only when needed, to balance risk and benefit of this exceptional class of drugs.…”